Clinical Trials Using Akt Inhibitor
Review the clinical trials studying akt inhibitor on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.
Trials 1-25 of
30
- Status: ActiveLocation: 573 locations
- Status: ActiveLocation: 19 locations
- Status: ActiveLocation: 33 locations
- Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)Status: ActiveLocation: 24 locations
- Status: ActiveLocation: 16 locations
- Status: ActiveLocation: 18 locations
- Status: ActiveLocation: 17 locations
- Status: ActiveLocation: 24 locations
- Status: ActiveLocation: 10 locations
- Status: ActiveLocation: 10 locations
- Status: ActiveLocation: 9 locations
- Status: ActiveLocation: 7 locations
- Status: ActiveLocation: 6 locations
- Status: ActiveLocation: 6 locations
- Status: ActiveLocation: 6 locations
- Status: ActiveLocation: 2 locations
- Status: ActiveLocation: 2 locations
- Status: ActiveLocation: 2 locations
- Status: ActiveLocation: 3 locations
- Status: ActiveLocation: 4 locations
- Status: ActiveLocation: M D Anderson Cancer Center, Houston, Texas
- Status: ActiveLocation: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
- Status: ActiveLocation: M D Anderson Cancer Center, Houston, Texas
- Status: ActiveLocation: M D Anderson Cancer Center, Houston, Texas
- Status: ActiveLocation: See ClinicalTrials.gov